US Patent 7595333 Agent for improving acidosis
Patent 7595333 was granted and assigned to Takeda Pharmaceutical Company on September, 2009 by the United States Patent and Trademark Office.
All edits
Edits on 16 Sep, 2023
Golden AI
Edits made to:
Article (+132 characters)
Article
Patent abstract
An agent for improving ketosis which comprises an insulin sensitizer, which has an excellent action and low toxicity.
Edits on 25 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 19 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07595333 Agent for improving acidosis US Patent 7595333 Agent for improving acidosis
Infobox
Patent Number
0759533300
Patent Number
759533300
Edits on 28 Mar, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
075953330
Date of Patent
September 29, 2009
0Patent Application Number
107177380
Date Filed
November 20, 2003
0Official Website
Patent Primary Examiner
Edits on 27 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
075953330
Date of Patent
September 29, 2009
0Patent Application Number
107177380
Date Filed
November 20, 2003
0Official Website
Patent Primary Examiner
Edits on 18 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 3 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07595333 Agent for improving acidosis
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07595333
Date of patent
September 29, 2009
Patent application number
10717738
Date Filed
November 20, 2003
Patent primary examiner
Find more entities like US Patent 7595333 Agent for improving acidosis
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
